These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23772507)

  • 1. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment topics: I. Pathophysiology, diagnosis and treatment; 13. Late onset hypogonadism syndrome].
    Horie S
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):914-21. PubMed ID: 23772507
    [No Abstract]   [Full Text] [Related]  

  • 2. Late-onset hypogonadism: metabolic impact.
    Grossmann M; Ng Tang Fui M; Cheung AS
    Andrology; 2020 Nov; 8(6):1519-1529. PubMed ID: 31502758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation, treatment and monitoring of late-onset hypogonadism in males.
    Nieschlag E; Swerdloff R; Behre HM; Gooren LJ; Kaufman JM; Legros JJ; Lunenfeld B; Morley JE; Schulman C; Wang C; Weidner W; Wu FC
    Aging Male; 2005 Jun; 8(2):56-8. PubMed ID: 16096159
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men - a suggested update.
    Lunenfeld B; Mskhalaya G; Kalinchenko S; Tishova Y
    Aging Male; 2013 Dec; 16(4):143-50. PubMed ID: 24188520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An idiopathic hypogonadotropic hypogonadism patient with metabolic disorder and diabetes: case report.
    Zhang MN; Su B; Qian CH; Bu L; Cheng XY; Li WJ; Qu S
    Asian J Androl; 2015; 17(2):341-2. PubMed ID: 25337838
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment and management of male androgen disorders: an update.
    Chan I; Fui MN; Zajac JD; Grossmann M
    Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone replacement in men.
    Beg S; Al-Khoury L; Cunningham GR
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
    Turchi P; Simi S; Pescatori ES
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Christina Wang, Eberhard Nieschlag, Ronald Swerdloff, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol 2009;55:121-30.
    Ponholzer A; Madersbacher S
    Eur Urol; 2009 May; 55(5):e92; author reply e93-4. PubMed ID: 19081175
    [No Abstract]   [Full Text] [Related]  

  • 10. Testosterone replacement therapy.
    Jones TH
    Br J Hosp Med (Lond); 2007 Oct; 68(10):547-53. PubMed ID: 17974303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [LOH (late-onset hypogonadism].
    Itoh N; Hisasue S; Tsukamoto T
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():499-503. PubMed ID: 16689357
    [No Abstract]   [Full Text] [Related]  

  • 12. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    Gould DC; Kirby RS
    Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes.
    Corona G; Rastrelli G; Maggi M
    Best Pract Res Clin Endocrinol Metab; 2013 Aug; 27(4):557-79. PubMed ID: 24054931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
    Johansen KL
    Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical decisions. Testosterone-replacement therapy.
    Swerdloff R; Anawalt BD
    N Engl J Med; 2014 Nov; 371(21):2032-4. PubMed ID: 25409377
    [No Abstract]   [Full Text] [Related]  

  • 17. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
    Mäkinen JI; Huhtaniemi I
    Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum testosterone levels in male hypogonadism: Why and when to check-A review.
    Livingston M; Kalansooriya A; Hartland AJ; Ramachandran S; Heald A
    Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28980739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.